Amgen (AMGN) Share-based Compensation (2009 - 2026)
Amgen's Share-based Compensation came in at $128 million for Q3 2026, up 0.8% from $127 million a year earlier but down 22.4% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Share-based Compensation (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Amgen reported Share-based Compensation of $493 million, down 2.0% year-over-year; for FY2025, it came in at $494 million, down 6.8% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $530 million in FY2024 (+23.0%), $431 million in FY2023 (+7.5%), $401 million in FY2022 (+17.6%) and $341 million in FY2021 (+3.3%).
- The five-year range for quarterly Share-based Compensation is $47 million (Q1 2023) to $165 million (Q2 2026).
- Year-over-year, Share-based Compensation increased in two of the last eight quarters, with an average decline of 6.7%.
- The fastest year-over-year change in Share-based Compensation over five years came in Q1 2024 (growth of 119.1%), and the weakest in Q1 2025 (a decline of 17.5%).
- Business Quant data shows AMGN's Share-based Compensation at $165 million (Q2 2026), $75 million (Q1 2026) and $125 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 174.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 128.00 Mn |
| Jun 30, 2026 | 165.00 Mn |
| Mar 31, 2026 | 75.00 Mn |
| Dec 31, 2025 | 125.00 Mn |
| Sep 30, 2025 | 127.00 Mn |
| Jun 30, 2025 | 157.00 Mn |
| Mar 31, 2025 | 85.00 Mn |
| Dec 31, 2024 | 134.00 Mn |
| Sep 30, 2024 | 136.00 Mn |
| Jun 30, 2024 | 157.00 Mn |
| Mar 31, 2024 | 103.00 Mn |
| Dec 31, 2023 | 161.00 Mn |
| Sep 30, 2023 | 104.00 Mn |
| Jun 30, 2023 | 119.00 Mn |
| Mar 31, 2023 | 47.00 Mn |
| Dec 31, 2018 | 87.00 Mn |
| Sep 30, 2018 | 77.00 Mn |
| Jun 30, 2018 | 93.00 Mn |
| Mar 31, 2018 | 54.00 Mn |
| Dec 31, 2017 | 85.00 Mn |
API Access
Amgen Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();